Study on the precise mechanism of Mitoxantrone-induced Jurkat cell apoptosis using surface enhanced Raman scattering

Spectrochim Acta A Mol Biomol Spectrosc. 2020 Mar 5:228:117718. doi: 10.1016/j.saa.2019.117718. Epub 2019 Nov 28.

Abstract

Mitoxantrone (MTX), one representative of anthraquinone ring anticancer drugs, reveals excellent anticancer effects in acute leukemia. Though current studies have shown that MTX-induced acute leukemia cell apoptosis is implemented by inserting into DNA, and then leading to DNA breakage and the subsequent transcription termination, but the specific location information of MTX embedded in DNA remains unknown. In this study, combining surface enhanced Raman scattering (SERS) and principal component analysis (PCA), we achieve the biochemical changes of MTX-induced Jurkat cell apoptosis and the location information of MTX embedded in DNA. In contrast, we also present the corresponding result of Daunorubicin (DNR)-induced Jurkat cell apoptosis. It is found that the location of MTX embedded in DNA of Jurkat cell is different from DNR, in which the action site of MTX is mainly implemented by blocking and destroying AT base pairs while DNR is performed by embedding and destroying GC base pairs and then the base A. Clearly, this achieved information is very useful for the designing and modification of anthraquinone ring anticancer drugs.

Keywords: Apoptosis; Jurkat cell; Mitoxantrone; Surface enhanced Raman scattering.

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects*
  • DNA / chemistry
  • DNA / genetics
  • Humans
  • Intercalating Agents / pharmacology*
  • Jurkat Cells
  • Leukemia, T-Cell / drug therapy*
  • Leukemia, T-Cell / genetics
  • Mitoxantrone / pharmacology*
  • Spectrum Analysis, Raman

Substances

  • Antineoplastic Agents
  • Intercalating Agents
  • DNA
  • Mitoxantrone